Mani Foroohar
Stock Analyst at Leerink Partners
(0.21)
# 4,591
Out of 5,010 analysts
946
Total ratings
43.6%
Success rate
-4.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mani Foroohar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RCKT Rocket Pharmaceuticals | Reiterated: Hold | n/a | $2.59 | - | 56 | Sep 16, 2026 | |
| ENGN enGene Therapeutics | Reiterated: Hold | $2 | $1.95 | +2.56% | 14 | Sep 9, 2026 | |
| ABSI Absci | Initiated Coverage: Buy | $12 | $10.14 | +18.34% | 1 | Jun 4, 2026 | |
| MIRM Mirum Pharmaceuticals | Reiterated: Buy | $100 → $154 | $87.54 | +75.92% | 54 | May 15, 2026 | |
| RGNX REGENXBIO | Reiterated: Buy | $17 | $7.45 | +128.19% | 64 | May 15, 2026 | |
| NTLA Intellia Therapeutics | Reiterated: Buy | $27 → $35 | $12.03 | +190.94% | 52 | Apr 27, 2026 | |
| CAMP Camp4 Therapeutics | Reiterated: Buy | $8 → $9 | $3.92 | +129.59% | 7 | Apr 2, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Reiterated: Hold | n/a | $66.25 | - | 56 | Mar 26, 2026 | |
| MRNA Moderna | Reiterated: Sell | $12 | $203.46 | -94.10% | 89 | Feb 11, 2026 | |
| ALNY Alnylam Pharmaceuticals | Reiterated: Hold | $370 → $351 | $254.07 | +38.15% | 67 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $370 → $86 | $65.97 | +30.36% | 76 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $68 → $100 | $45.89 | +117.91% | 67 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $2 | $0.5931 | +237.21% | 16 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $18 | $3.42 | +426.32% | 16 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 → $74 | $56.00 | +32.14% | 27 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $14.49 | - | 41 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.03 | - | 34 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $51 → $48 | $47.75 | n/a | 2 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $9.75 | n/a | 9 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $24.52 | n/a | 20 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $27 | $30.33 | n/a | 12 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.24 | n/a | 32 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $28.39 | n/a | 13 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $2.59 | n/a | 20 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $2.90 | n/a | 31 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.84 | n/a | 3 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 | $3.86 | n/a | 15 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $67.33 | n/a | 1 | Jun 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $5 | $3.64 | n/a | 24 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $6 | $5.16 | n/a | 17 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $23.34 | n/a | 7 | Oct 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $216 → $197 | $18.64 | n/a | 3 | Nov 6, 2020 |
Rocket Pharmaceuticals
Sep 16, 2026
Reiterated: Hold
Price Target: n/a
Current: $2.59
Upside: -
enGene Therapeutics
Sep 9, 2026
Reiterated: Hold
Price Target: $2
Current: $1.95
Upside: +2.56%
Absci
Jun 4, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $10.14
Upside: +18.34%
Mirum Pharmaceuticals
May 15, 2026
Reiterated: Buy
Price Target: $100 → $154
Current: $87.54
Upside: +75.92%
REGENXBIO
May 15, 2026
Reiterated: Buy
Price Target: $17
Current: $7.45
Upside: +128.19%
Intellia Therapeutics
Apr 27, 2026
Reiterated: Buy
Price Target: $27 → $35
Current: $12.03
Upside: +190.94%
Camp4 Therapeutics
Apr 2, 2026
Reiterated: Buy
Price Target: $8 → $9
Current: $3.92
Upside: +129.59%
Arrowhead Pharmaceuticals
Mar 26, 2026
Reiterated: Hold
Price Target: n/a
Current: $66.25
Upside: -
Moderna
Feb 11, 2026
Reiterated: Sell
Price Target: $12
Current: $203.46
Upside: -94.10%
Alnylam Pharmaceuticals
Dec 15, 2025
Reiterated: Hold
Price Target: $370 → $351
Current: $254.07
Upside: +38.15%
Dec 15, 2025
Reiterated: Buy
Price Target: $370 → $86
Current: $65.97
Upside: +30.36%
Dec 15, 2025
Reiterated: Buy
Price Target: $68 → $100
Current: $45.89
Upside: +117.91%
Dec 15, 2025
Reiterated: Buy
Price Target: $3 → $2
Current: $0.5931
Upside: +237.21%
Oct 21, 2025
Reiterated: Buy
Price Target: $20 → $18
Current: $3.42
Upside: +426.32%
Oct 15, 2025
Reiterated: Buy
Price Target: $56 → $74
Current: $56.00
Upside: +32.14%
Oct 15, 2025
Reiterated: Buy
Price Target: n/a
Current: $14.49
Upside: -
Oct 15, 2025
Reiterated: Hold
Price Target: n/a
Current: $4.03
Upside: -
Sep 25, 2025
Reiterated: Buy
Price Target: $51 → $48
Current: $47.75
Upside: n/a
Sep 23, 2025
Reiterated: Buy
Price Target: $20
Current: $9.75
Upside: n/a
Sep 3, 2025
Reiterated: Buy
Price Target: n/a
Current: $24.52
Upside: n/a
Aug 18, 2025
Reiterated: Buy
Price Target: $32 → $27
Current: $30.33
Upside: n/a
Aug 13, 2025
Reiterated: Buy
Price Target: $3
Current: $1.24
Upside: n/a
Aug 12, 2025
Reiterated: Buy
Price Target: $70
Current: $28.39
Upside: n/a
Mar 6, 2025
Reiterated: Hold
Price Target: $1
Current: $2.59
Upside: n/a
Aug 9, 2024
Reiterated: Hold
Price Target: $1
Current: $2.90
Upside: n/a
Jul 15, 2024
Reiterated: Buy
Price Target: n/a
Current: $7.84
Upside: n/a
Nov 13, 2023
Reiterated: Hold
Price Target: $21
Current: $3.86
Upside: n/a
Jun 8, 2023
Reiterated: Sell
Price Target: n/a
Current: $67.33
Upside: n/a
May 23, 2023
Reiterated: Hold
Price Target: $6 → $5
Current: $3.64
Upside: n/a
Nov 14, 2022
Reiterated: Hold
Price Target: $5 → $6
Current: $5.16
Upside: n/a
Oct 19, 2021
Reiterated: Hold
Price Target: n/a
Current: $23.34
Upside: n/a
Nov 6, 2020
Reiterated: Buy
Price Target: $216 → $197
Current: $18.64
Upside: n/a